Product Information
DOCUSATE SODIUM 100 MG SOFTGEL is a generic product labeled by Major Pharmaceuticals, priced at $0.0276 per EA under NDC 00904728080. Its NADAC has been published 181 times since Apr 19, 2023.
The High Outlier badge above means this manufacturer's average price in the DOCUSATE SODIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904728080
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOCUSATE SODIUMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
11/15/2022
Price Statistics
The NADAC for DOCUSATE SODIUM 100 MG SOFTGEL has been published 181 times since Apr 19, 2023, and over the history we have for it it has risen 18.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0276 per EA |
|---|---|
| All-time high | $0.0321 (Jun 14, 2023) |
| All-time low | $0.0209 (May 22, 2024) |
| 52-week high | $0.0300 |
| 52-week low | $0.0272 |
| Median price | $0.0271 |
| Average price | $0.0265 |
| Largest weekly change | +37.8% (May 17, 2023) |
| Weeks tracked | 181 |
| Tracking since | Apr 19, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DOCUSATE SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOCUSATE SODIUM 100 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for DOCUSATE SODIUM 100 MG SOFTGEL, manufactured by Major Pharmaceuticals, is $0.0276 per EA (NDC 00904728080), effective Sep 30, 2026.
How has the price of DOCUSATE SODIUM 100 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for DOCUSATE SODIUM 100 MG SOFTGEL has risen 18.5%. It has been tracked across 181 weekly CMS publications since Apr 19, 2023.
What are the highest and lowest recorded NADAC prices for DOCUSATE SODIUM 100 MG SOFTGEL?
Since Apr 19, 2023, the NADAC for DOCUSATE SODIUM 100 MG SOFTGEL has ranged from a low of $0.0209 (May 22, 2024) to a high of $0.0321 (Jun 14, 2023), with a median of $0.0271 per EA.
Are there cheaper alternatives to DOCUSATE SODIUM 100 MG SOFTGEL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC STOOL SOFTENER 100 MG SFTGL, is $0.0253 per EA — about 8% below DOCUSATE SODIUM 100 MG SOFTGEL.
Who manufactures DOCUSATE SODIUM 100 MG SOFTGEL?
DOCUSATE SODIUM 100 MG SOFTGEL (NDC 00904728080) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.